01:59:24 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



SEC defendant Rayat settles Renovacare charges

2023-12-19 20:16 ET - Street Wire

Also Street Wire (U-RCAR) Renovacare Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

Vancouver's Harmel Singh Rayat has reached an out-of-court deal to settle civil charges he faces from the U.S. Securities and Exchange Commission over the Renovacare Inc. scheme. The SEC claims that Mr. Rayat boosted the company with a supposed burn healing device called the "SkinGun." People associated with him realized millions of dollars in gains amidst a $50,000-per-month paid touting campaign, the SEC says. (All figures are in U.S. dollars.)

Mr. Rayat's settlement is set out in a letter to the judge filed on Friday, Dec. 15, in federal court in New York. According to the letter, recent talks between Mr. Rayat and the SEC have produced a settlement that will resolve the matter in its entirety. Both sides have requested that the judge stay all deadlines in the case while the matter goes to the SEC's commissioners for approval (a process that takes about two months).

The letter does not disclose the terms of the settlement, but when it filed the case the SEC had sought a court order banning Mr. Rayat from penny stocks and from serving as an officer or director. The SEC had also sought disgorgement of Mr. Rayat's gains, although calculating that figure may not be straightforward. The SEC said that he indirectly received some of the scheme's $7.5-million in gains through an "estate planning transaction" that his accountant devised.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.